AngelList acquires Ark to build fund software spanning private markets
What's the deal? AngelList has acquired ArkDealroom has a profile for this one. Try Dealroom → PES, a fund management software platform serving more than 500 general partners (GPs) and fund administrators across venture capital and private equity. Terms were not disclosed. Ark supports more than $185 billion in assets; AngelList's platform supports over $170 billion.
What's the endgame? AngelList wants to build "the financial system for the private markets." The deal folds Ark's fund administration software into AngelList's banking, payments, cap table, and AI capabilities, creating a single platform spanning the fund lifecycle.
The details: The combined offering will cover cap table, portfolio monitoring, fund administration, and investor relations, including fundraising, CRM, and e-subscription documents. AngelList's banking network will let Ark's clients clear capital calls, distributions, and subscriptions "in minutes instead of days." AngelList counts over 150,000 accredited investors on that network.
Why now? AngelList plans to support Ark's rollout of AI across fund accounting, investor reporting, and fundraising, aiming to cut manual work and improve accuracy. "Bringing these companies together will create significant benefits to customers, enhancing our AI capabilities and driving innovation and product development," said chief executive officer Avlok Kohli.
What they're saying: "Joining AngelList allows us to accelerate that mission," said Bill Ward, chief executive officer of Ark. He said customers will gain "integrated banking and payments capabilities that can meaningfully improve how funds are administered and serviced."
The signal: The tie-up reflects a broader consolidation of private markets infrastructure, as software providers race to bundle fund administration, banking, and AI into one platform. With AngelList's 25,000-plus funds and syndicates and Ark's 500 administrators, the combined business is betting that scale and automation will win an increasingly complex market.
Read more: Associated Press
